Insider Trading activities of Aptevo Therapeutics Inc. (APVO)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aptevo Therapeutics Inc. (APVO) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aptevo Therapeutics Inc. since year 2005. Table 2 shows the detailed insider transactions of Aptevo Therapeutics Inc. since 2005. The reporting company's ticker symbol is APVO. The reporting company's CIK number is 1671584.
The total value of stock buying since 2005 is $357,018.
The total value of stock sales since 2005 is $293,000.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aptevo Therapeutics Inc. (APVO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-07 104,985 $91,218 0 $0 0 $0
2019-06 126,667 $106,480 0 $0 0 $0
2019-05 70,000 $54,670 0 $0 0 $0
2019-03 0 $0 0 $0 46,830 $0
2018-12 15,000 $35,650 0 $0 0 $0
2018-08 0 $0 0 $0 1,630 $0
2018-05 0 $0 0 $0 35,644 $0
2018-03 0 $0 100,000 $293,000 63,096 $0
2018-02 0 $0 0 $0 70,857 $0
2017-11 25,000 $69,000 0 $0 0 $0
2017-08 0 $0 0 $0 116,216 $0
2017-05 0 $0 0 $0 53,471 $0
2017-03 0 $0 0 $0 121,309 $0
2017-02 0 $0 0 $0 70,856 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aptevo Therapeutics Inc. insiders (APVO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-07-19 El-hibri Fuad (Board of Directors) Buy 26,460 .90 23,734
2019-07-18 El-hibri Fuad (Board of Directors) Buy 14,404 .88 12,603
2019-07-17 El-hibri Fuad (Board of Directors) Buy 19,136 .87 16,705
2019-07-16 El-hibri Fuad (Board of Directors) Buy 11,375 .85 9,657
2019-07-11 El-hibri Fuad (Board of Directors) Buy 14,691 .85 12,457
2019-07-10 El-hibri Fuad Buy 18,919 .85 16,062
2019-06-25 Abdun-nabi Daniel (Board of Directors) Buy 16,667 .90 15,000
2019-06-14 White Marvin L (President and CEO) Buy 50,000 .88 44,000
2019-06-10 Kunz Barbara Lopez (Board of Directors) Buy 10,000 .85 8,480
2019-06-07 Harsanyi Zsolt (Board of Directors) Buy 50,000 .78 39,000
2019-05-31 Maddux Randy Joe (Senior VP, Operations) Buy 20,000 .73 14,600
2019-05-21 Grant Grady Iii (Board of Directors) Buy 10,000 .80 7,970
2019-05-20 White Marvin L (President and CEO) Buy 30,000 .81 24,300
2019-05-14 White Marvin L (President and CEO) Buy 10,000 .78 7,800
2019-03-01 Adelman Michael (SVP, Commercial Operations) Option Ex 7,318 .00 0
2019-03-01 Mitchell Shawnte (SVP, GC and Corporate Affairs) Option Ex 6,787 .00 0
2019-03-01 Gross Jane A (See Remarks) Option Ex 9,138 .00 0
2019-03-01 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 16,269 .00 0
2019-03-01 Lamothe Jeffrey G. (SVP and CFO) Option Ex 7,318 .00 0
2018-12-06 Maddux Randy Joe (SVP Operations) Buy 5,000 2.37 11,850
2018-12-04 White Marvin L (President and CEO) Buy 10,000 2.38 23,800
2018-08-09 Mitchell Shawnte (SVP, GC and Corporate Affairs) Option Ex 1,630 .00 0
2018-05-21 White Marvin L (President and CEO) Option Ex 35,644 .00 0
2018-03-19 White Marvin L (President and CEO) Sale 100,000 2.93 293,000
2018-03-10 Lamothe Jeffrey G. (SVP, CFO and Treasurer) Option Ex 6,747 .00 0
2018-03-09 Gross Jane A (See Remarks) Option Ex 9,728 .00 0
2018-03-09 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 13,892 .00 0
2018-03-01 Gross Jane A (See Remarks) Option Ex 9,140 .00 0
2018-03-01 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 16,269 .00 0
2018-03-01 Lamothe Jeffrey G. (SVP, CFO and Treasurer) Option Ex 7,320 .00 0
2018-02-03 Gross Jane A (See Remarks) Option Ex 18,136 .00 0
2018-02-03 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 27,381 .00 0
2018-02-03 Lamothe Jeffrey G. (SVP, CFO and Treasurer) Option Ex 25,340 .00 0
2017-11-15 Maddux Randy Joe (Senior VP, Operations) Buy 25,000 2.76 69,000
2017-08-01 Gross Jane A (See Remarks) Option Ex 38,093 .00 0
2017-08-01 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 78,123 .00 0
2017-05-22 White Marvin L (President and CEO) Option Ex 53,471 .00 0
2017-03-10 Gross Jane A (See Remarks) Option Ex 14,506 .00 0
2017-03-10 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 24,836 .00 0
2017-03-10 Lamothe Jeffrey G. (SVP, CFO and Treasurer) Option Ex 18,863 .00 0
2017-03-09 Gross Jane A (See Remarks) Option Ex 9,727 .00 0
2017-03-09 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 13,902 .00 0
2017-03-01 Gross Jane A (See Remarks) Option Ex 9,140 .00 0
2017-03-01 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 16,269 .00 0
2017-03-01 Lamothe Jeffrey G. (SVP, CFO and Treasurer) Option Ex 14,066 .00 0
2017-02-03 Gross Jane A (See Remarks) Option Ex 18,135 .00 0
2017-02-03 Stromatt Scott C (Chief Medical Officer and SVP) Option Ex 27,381 .00 0
2017-02-03 Lamothe Jeffrey G. (SVP, CFO and Treasurer) Option Ex 25,340 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of APVO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aptevo Therapeutics Inc. (symbol APVO, CIK number 1671584) see the Securities and Exchange Commission (SEC) website.